{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:37:24Z","timestamp":1781307444927,"version":"3.54.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,14]]},"DOI":"10.1097\/01.aids.0000434936.57880.cd","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T22:48:34Z","timestamp":1380322114000},"page":"245-255","source":"Crossref","is-referenced-by-count":18,"title":["The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy"],"prefix":"10.1097","volume":"28","author":[{"given":"Heidi M.","family":"Soeters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Napravnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monita R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Eron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-12-20210130","first-page":"231","article-title":"Management of tuberculosis in HIV-infected patients.","volume":"14","author":"Curran","year":"2012","journal-title":"AIDS Rev"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.5588\/ijtld.11.0693","article-title":"Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.","volume":"16","author":"Breton","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis.","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.2010.310","article-title":"Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.","volume":"303","author":"Bassler","year":"2010","journal-title":"JAMA"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R16-12-20210130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/aid.2010.0200","article-title":"Rapid suppression of HIV-RNA is associated with improved control of immune activation in Mozambican adults initiating antiretroviral therapy with low CD4 counts.","volume":"27","author":"Almeida","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"e49091","DOI":"10.1371\/journal.pone.0049091","article-title":"Timeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patients.","volume":"7","author":"Bastard","year":"2012","journal-title":"PLoS One"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/jama.300.5.530","article-title":"Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.","volume":"300","author":"Boulle","year":"2008","journal-title":"JAMA"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/503437","article-title":"Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.","volume":"193","author":"Breen","year":"2006","journal-title":"J Infect Dis"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/cir900","article-title":"Impaired CD4 T-Cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.","volume":"54","author":"Cingolani","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/157016211796320324","article-title":"Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.","volume":"9","author":"Dronda","year":"2011","journal-title":"Curr HIV Res"},{"key":"R23-12-20210130","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1097\/00002030-200312050-00008","article-title":"Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.","volume":"17","author":"Hung","year":"2003","journal-title":"AIDS"},{"key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"e31161","DOI":"10.1371\/journal.pone.0031161","article-title":"Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected ZuluXhosa in South Africa.","volume":"7","author":"Julg","year":"2012","journal-title":"PLoS One"},{"key":"R25-12-20210130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/cid\/ciq196","article-title":"Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.","volume":"52","author":"Lartey","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R26-12-20210130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2334-8-136","article-title":"Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients withwithout prior co-administration of rifampicin: a 144-week prospective study.","volume":"8","author":"Manosuthi","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1016\/j.ijid.2010.06.016","article-title":"Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.","volume":"14","author":"Manosuthi","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R28-12-20210130","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/QAD.0b013e328314b5f1","article-title":"Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.","volume":"22","author":"Mussini","year":"2008","journal-title":"AIDS"},{"key":"R29-12-20210130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.qai.0000135956.96166.f0","article-title":"Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1.","volume":"37","author":"Patel","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-12-20210130","first-page":"360","article-title":"Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana.","volume":"13","author":"Shipton","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"R31-12-20210130","doi-asserted-by":"crossref","first-page":"e53022","DOI":"10.1371\/journal.pone.0053022","article-title":"Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.","volume":"8","author":"Siika","year":"2013","journal-title":"PLoS ONE"},{"key":"R32-12-20210130","first-page":"117","article-title":"Clinical manifestations and antiretroviral management of HIVAIDS patients with tuberculosis co-infection in Kramat 128 Hospital.","volume":"40","author":"Sumantri","year":"2008","journal-title":"Acta Med Indones"},{"key":"R33-12-20210130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4103\/0377-4929.72070","article-title":"CD4 cell count recovery in HIVTB co-infected patients versus TB uninfected HIV patients.","volume":"53","author":"Wanchu","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R39-12-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/505210","article-title":"Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.","volume":"43","author":"Manosuthi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R40-12-20210130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e328333bfb7","article-title":"Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.","volume":"24","author":"Boulle","year":"2010","journal-title":"AIDS"},{"key":"R41-12-20210130","doi-asserted-by":"crossref","first-page":"e18453","DOI":"10.1371\/journal.pone.0018453","article-title":"Four-year treatment outcomes of adult patients enrolled in Mozambiques rapidly expanding antiretroviral therapy program.","volume":"6","author":"Auld","year":"2011","journal-title":"PLoS One"},{"key":"R42-12-20210130","doi-asserted-by":"crossref","first-page":"e40180","DOI":"10.1371\/journal.pone.0040180","article-title":"Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania.","volume":"7","author":"Mugusi","year":"2012","journal-title":"PLoS One"},{"key":"R43-12-20210130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/QAI.0b013e318288b39d","article-title":"Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.","volume":"63","author":"Schomaker","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-12-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/QAI.0b013e31823d3aba","article-title":"Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.","volume":"59","author":"Bassett","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-12-20210130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy.","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"R46-12-20210130","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment.","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"R47-12-20210130","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.","volume":"365","author":"Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"R48-12-20210130","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.","volume":"365","author":"Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"R49-12-20210130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/QAD.0b013e328325d115","article-title":"Effect of pulmonary tuberculosis on mortality in patients receiving HAART.","volume":"23","author":"Westreich","year":"2009","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.aids.0000434936.57880.cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:47:18Z","timestamp":1620935238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201401140-00012"}},"subtitle":["a systematic review"],"short-title":[],"issued":{"date-parts":[[2014,1,14]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000434936.57880.cd","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,14]]}}}